Rong Wang

机构：Jiangsu University, Shanxi Medical University, Lanzhou University of Technology, Nanjing Children's Hospital, Jiangsu T-mab BioPharma (China), Shandong Provincial Hospital, First Hospital of Shanxi Medical University, Second Affiliated Hospital of Nanjing Medical University, Lanzhou University of Finance and Economics, Shandong First Medical University, Lanzhou University, Nanjing Medical University · ORCID：0000-0003-2077-3249

发表论文 67 篇 · 总被引 955 次 · h-index 16

代表论文

• Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis (2023 · JAMA Network Open · 被引 125)
• Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathy (2025 · Clinical Kidney Journal · 被引 15)
• Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho (2023 · Renal Failure · 被引 12)
• Histone modification–mediated epigenetic regulation in AKI-to-CKD transition: a cell-type-specific perspective (2025 · Journal of Translational Medicine · 被引 10)
• Effect of roxadustat on red blood cell lifespan in patients with long-term haemodialysis: a single-centre, prospective, single-arm study (2023 · Clinical Kidney Journal · 被引 10)
• A human bispecific antibody neutralizes botulinum neurotoxin serotype A (2023 · Scientific Reports · 被引 9)